Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer: Eight-year progress report
- 1 May 1972
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 15 (3) , 169-174
- https://doi.org/10.1007/bf02589856
Abstract
An eight-year progress report of a method of intraluminal chemotherapy adjuvant to operation for cancer of the colon and rectum is presented. The technic involves sequestering the diseased segment between tape ligatures. A cancericidal drug is injected into the lumen within the taped area. The clamping of the pedicle vessels is deliberately delayed 30 minutes to allow maximal absorption of drug. In the 5-FU-treated group, the agent is also injected intravenously on postoperative days 1 and 2. Seventy-seven patients (excluding four postoperative deaths) in the treated series were followed for as long as eight years. No significant increase in morbidity or mortality was associated with this technic. Follow-up studies of 5-FU-treated patients with Stage III cancers (positive mesenteric nodes) indicate that the trend toward increased survival of Stage III patients noted at five years continues to be sustained at eight years.Keywords
This publication has 5 references indexed in Scilit:
- A five year progress report on the effectiveness of intraluminal chemotherapy (5-fluorouracil) adjuvant to surgery for colorectal cancerThe American Journal of Surgery, 1968
- Cancer Of The ColonAnnals of Surgery, 1967
- The Use Of Triethylenethiophosphoramide As An Adjuvant To The Surgical Treatment Of Colorectal CarcinomaAnnals of Surgery, 1967
- Intraluminal chemotherapy (HN2 or 5-FU) adjuvant to operation for cancer of the colon and rectum.II. Follow-up report of 97 casesCancer, 1967
- Chemotherapy for Colorectal CancerSurgical Clinics of North America, 1965